A multicenter, single arm, open label, Phase IV study to evaluate safety and to describe the
cumulative incidence of major cardiovascular events of Ticagrelor in Taiwanese patients with
non ST-segment (a segment in the eletrocardiogram which presents the period when ventricles
are depolarized) elevation myocardial infarction